Clinical Trials · NCT01952145
A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes Mellitus
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 557
- Start date
- Sep 2013
- Locations
- 91 sites, 10 countries
- Primary endpoint
- Change From Baseline in HbA1c (Glycosylated Haemoglobin)